Meyka Pro is live. Get 50% off your first 3 months.Get Started →
ENDRA Life Sciences Inc. Warrants

ENDRA Life Sciences Inc. Warrants (NDRAW) Stock Overview

Explore ENDRA Life Sciences Inc. Warrants’s financial performance, market position, analyst ratings, and future outlook.

NDRAW●NASDAQ
HealthcareMedical - Diagnostics & Research
$0.03
$0.02(150.00%)
U.S. Market is Open · 15:30

ENDRA Life Sciences Inc. Warrants (NDRAW)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-0.65
EPS (TTM)N/A
ROE-5.13%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.10
3 Months$0.04
1 Year Target$0.02

NDRAW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ENDRA Life Sciences Inc. Warrants (NDRAW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.65 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
-76.92%
All-Time (Max) Change
-96.84%

Contact Information

NaN
NaN
NaN, NaN, DE, NaN

Company Facts

IPO DateJun 28, 2017
CountryUS

Frequently Asked Questions